RT Journal Article
SR Electronic
T1 Genomic monitoring unveil the early detection of the SARS-CoV-2 B.1.351 lineage (20H/501Y.V2) in Brazil
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2021.03.30.21254591
DO 10.1101/2021.03.30.21254591
A1 Slavov, Svetoslav Nanev
A1 Leister Patané, José Salvatore
A1 Santos Bezerra, Rafael dos
A1 Giovanetti, Marta
A1 Fonseca, Vagner
A1 Martins, Antonio Jorge
A1 Viala, Vincent Louis
A1 Rodrigues, Evandra Strazza
A1 dos Santos, Elaine Vieira
A1 dos Santos Barros, Claudia Renata
A1 Marqueze, Elaine Cristina
A1 Santos, Bibiana
A1 Aburjaile, Flavia
A1 Neto, Raul Machado
A1 Moretti, Debora Botequio
A1 Haddad, Ricardo
A1 Calado, Rodrigo Tocantins
A1 Paulo Kitajima, João
A1 Freitas, Erika
A1 Schlesinger, David
A1 de Alcantara, Luiz Carlos Junior
A1 Elias, Maria Carolina
A1 Sampaio, Sandra Coccuzzo
A1 Kashima, Simone
A1 Covas, Dimas Tadeu
YR 2021
UL http://medrxiv.org/content/early/2021/04/04/2021.03.30.21254591.abstract
AB Sao Paulo State, the most populous area in Brazil, currently experiences a second wave of the COVID-19 pandemic which overwhelmed the healthcare system. Recently, due to the paucity of SARS-CoV-2 complete genome sequences, we established a Network for Pandemic Alert of Emerging SARS-CoV-2 Variants to rapidly understand the spread of SARS-CoV-2 and monitor in nearly real-time the circulating SARS-CoV-2 variants into the state. Through full genome analysis of 217 SARS-CoV-2 complete genome sequences obtained from the largest regional health departments we were able to identify the co-circulation of multiple SARS-CoV-2 lineages such as i) B.1.1 (0.92%), ii) B.1.1.1 (0.46%), iii) B.1.1.28 (25.34%), iv) B.1.1.7 (5.99%), v) B.1.566 (1.84%), vi) P.1 (64.05%), and P.2 (0.92%). Further our analysis allowed the detection, for the first time in Brazil of the South African variant of concern (VOC), the B.1.351 (501Y.V2) (0.46%). The identified lineage was characterized by the presence of the following mutations: ORF1ab: T265I, R724K, S1612L, K1655N, K3353R, SGF 3675_F3677del, P4715L, E5585D; Spike: D80A, D215G, L242_L244del, A262D, K417N, E484K, N501Y, D614G, A701V, C1247F; ORF3a: Q57H, S171L, E: P71L; ORF7b: Y10F, N: T205I; ORF14: L52F. Origin of the most recent common ancestor of this genomic variant was inferred to be between middle October to late December 2020. Analysis of generated sequences demonstrated the predominance of the P.1 lineage and allowed the early detection of the South African strain for the first time in Brazil. Our findings highlight the importance to increase active monitoring to ensure the rapid detection of new SARS-CoV-2 variants with a potential impact in pandemic control and vaccination strategies.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was supported by Butantan Institute, Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (Grant Number. 2020/10127; 2020/05367-3), Hemocentro Ribeirao Preto.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This study is approved by the Institutional Ethics Committe of the Faculty of Medicine of Ribeirao Preto, University of Sao PauloAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe obtained data is being deposited in the GISAID database together with this submission.